National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, The First Affiliated Hospital, Nanchang University, Nanchang, China.
Basic Medical School, Nanchang University, Nanchang, China.
Front Endocrinol (Lausanne). 2020 Mar 20;11:134. doi: 10.3389/fendo.2020.00134. eCollection 2020.
Macrophage migration inhibitory factor (MIF) has multiple intrinsic enzymatic activities of the dopachrome/phenylpyruvate tautomerase and thiol protein oxidoreductase, and plays an important role in the development of obesity as a pro-inflammatory cytokine. However, which enzymatic activity of MIF is responsible for regulating in obesity are still unknown. In the present study, we investigated the roles of the tautomerase of MIF in high fat diet (HFD)-induced obesity using MIF tautomerase activity-lacking (MIF) mice. Our results showed that the serum MIF and the expression of MIF in adipose tissue were increased in HFD-treated mice compared with normal diet fed mice. The bodyweights were significantly reduced in MIF mice compared with WT mice fed with HFD. The sizes of adipocytes were smaller in MIF mice compared with WT mice fed with HFD using haematoxylin and eosin (H&E) staining. In addition, the MIF mice reduced the macrophage infiltration, seen as the decreases of the expression of inflammatory factors such as F4/80, IL-1β, TNFα, MCP1, and IL-6. The glucose tolerance tests (GTT) and insulin tolerance tests (ITT) assays showed that the glucose tolerance and insulin resistance were markedly improved, and the expressions of IRS and PPARγ were upregulated in adipose tissue from MIF mice fed with HFD. Furthermore, we observed that the expressions of Bax, a pro-apoptotic protein, and the cleaved caspase 3-positive cells in white tissues were decreased and the ratio of Bcl2/Bax was increased in MIF mice compared with WT mice. Taken together, our results demonstrated that the tautomerase activity-lacking of MIF significantly alleviated the HFD-induced obesity and adipose tissue inflammation, and improved insulin resistance in MIF mice.
巨噬细胞移动抑制因子(MIF)具有多巴胺/苯丙酮酸互变异构酶和硫醇蛋白氧化还原酶的多种内在酶活性,作为一种促炎细胞因子在肥胖的发展中发挥重要作用。然而,MIF 调节肥胖的哪种酶活性仍然未知。在本研究中,我们使用 MIF 互变异构酶活性缺乏(MIF)小鼠研究了 MIF 互变异构酶在高脂肪饮食(HFD)诱导的肥胖中的作用。
我们的结果表明,与正常饮食喂养的小鼠相比,HFD 处理的小鼠血清 MIF 和脂肪组织中 MIF 的表达增加。与 HFD 喂养的 WT 小鼠相比,MIF 小鼠的体重明显减轻。用苏木精和伊红(H&E)染色观察到,MIF 小鼠的脂肪细胞体积较小,HFD 喂养的 WT 小鼠。此外,MIF 小鼠减少了巨噬细胞浸润,表现为炎症因子如 F4/80、IL-1β、TNFα、MCP1 和 IL-6 的表达降低。葡萄糖耐量试验(GTT)和胰岛素耐量试验(ITT)表明,MIF 小鼠的葡萄糖耐量和胰岛素抵抗明显改善,HFD 喂养的 MIF 小鼠脂肪组织中 IRS 和 PPARγ 的表达上调。
此外,我们观察到 MIF 小鼠白色组织中促凋亡蛋白 Bax 的表达和 cleaved caspase 3 阳性细胞减少,Bcl2/Bax 比值增加。综上所述,我们的研究结果表明,MIF 的互变异构酶活性缺乏显著减轻了 HFD 诱导的肥胖和脂肪组织炎症,并改善了 MIF 小鼠的胰岛素抵抗。